Incidensen af disse bivirkninger er relateret til den indgivne dosis, patientens alder og muligvis omvendt relateret til patientens alder ved vækshormonmanglens start.
The incidence of these undesirable effects is related to the administered dose, the age of patients, and possibly inversely related to the age of patients at the onset of growth hormone deficiency.